MET097

· Metsera, a wholly owned subsidiary of Pfizer

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for MET097, covering 2026-01-28 to 2026-08-28. Get the full timeline:

Most recent: Clinical Trial Results: A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight [Phase 2]

See pricing